Panion & Bf Biotech Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 470.07 million compared to TWD 814.79 million a year ago. Net income was TWD 17.24 million compared to TWD 161.18 million a year ago. Basic earnings per share from continuing operations was TWD 0.2 compared to TWD 1.88 a year ago. Diluted earnings per share from continuing operations was TWD 0.2 compared to TWD 1.88 a year ago.
For the six months, sales was TWD 878.6 million compared to TWD 1,269.36 million a year ago. Net income was TWD 39.94 million compared to TWD 200.73 million a year ago. Basic earnings per share from continuing operations was TWD 0.47 compared to TWD 2.34 a year ago. Diluted earnings per share from continuing operations was TWD 0.47 compared to TWD 2.34 a year ago.